{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:16:06Z","timestamp":1767705366965,"version":"build-2065373602"},"reference-count":94,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003074","name":"ANPCyT","doi-asserted-by":"publisher","award":["PICT2014-620","PICT 2015-2544"],"award-info":[{"award-number":["PICT2014-620","PICT 2015-2544"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010567","name":"SECTeI","doi-asserted-by":"publisher","award":["SECTeI 2016: 2010-099-16"],"award-info":[{"award-number":["SECTeI 2016: 2010-099-16"]}],"id":[{"id":"10.13039\/501100010567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.015","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:49:44Z","timestamp":1559256584000},"page":"3628-3637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-2987","authenticated-orcid":false,"given":"Gabriel","family":"Cabrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Marcipar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.015_b0005","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.4049\/jimmunol.155.8.3955","article-title":"Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection","volume":"155","author":"Abrahamsohn","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/178947","article-title":"Immune evasion strategies of Trypanosoma cruzi","volume":"2015","author":"Fl\u00e1via Nardy","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0015","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4049\/jimmunol.140.8.2769","article-title":"Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells","volume":"140","author":"Tarleton","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0169-4758(95)80011-5","article-title":"Programmed T-cell death in experimental chagas disease","volume":"11","author":"DosReis","year":"1995","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2019.05.015_b0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/intimm\/dxf076","article-title":"Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+)immature myeloid suppressor cells","volume":"14","author":"Go\u00f1i","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/eji.201343606","article-title":"Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection","volume":"44","author":"Arocena","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0035","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.18217","article-title":"Trans-sialidase-based vaccine candidate protects against Trypanosoma cruzi infection, not only inducing an effector immune response but also affecting cells with regulatory\/suppressor phenotype","author":"Prochetto","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2019.05.015_b0040","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/IAI.01500-06","article-title":"Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice","volume":"75","author":"Kotner","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.micinf.2008.03.008","article-title":"The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi","volume":"10","author":"Sales","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.05.015_b0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbi.2014.11.016","article-title":"Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cells","volume":"45","author":"Gonz\u00e1lez","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.micinf.2008.04.009","article-title":"The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection","volume":"10","author":"Mariano","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.05.015_b0060","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.imbio.2012.04.008","article-title":"Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity","volume":"217","author":"de Ara\u00fajo","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0065","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1371\/journal.pntd.0000992","article-title":"Regulatory T cells phenotype in different clinical forms of Chagas\u2019 disease","volume":"5","author":"de Ara\u00fajo","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.015_b0070","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/IAI.67.8.4033-4040.1999","article-title":"Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules","volume":"67","author":"Van Overtvelt","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0075","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/IAI.01298-07","article-title":"Trypanosoma cruzi induces regulatory dendritic cells in vitro","volume":"76","author":"Poncini","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0080","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.4049\/jimmunol.1403019","article-title":"Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T Cells via galectin-1-dependent mechanisms","volume":"195","author":"Poncini","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0085","article-title":"Immunity and immune modulation in Trypanosoma cruzi infection","volume":"73","author":"Cardillo","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2019.05.015_b0090","doi-asserted-by":"crossref","first-page":"e1002658","DOI":"10.1371\/journal.ppat.1002658","article-title":"IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils","volume":"8","author":"Tosello Boari","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.05.015_b0095","doi-asserted-by":"crossref","first-page":"489758","DOI":"10.1155\/2015\/489758","article-title":"Experimental vaccines against chagas disease: a journey through history","volume":"2015","author":"Rodr\u00edguez-Morales","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0100","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects","volume":"11","author":"Dumonteil","year":"2012","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.05.015_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13071-015-0738-0","article-title":"Prophylactic and therapeutic DNA vaccines against Chagas disease","volume":"8","author":"Arce-Fonseca","year":"2015","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2019.05.015_b0110","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1586\/erv.09.45","article-title":"Vaccination approaches against Trypanosoma cruzi infection","volume":"8","author":"Cazorla","year":"2009","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.05.015_b0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0008-8749(79)90180-1","article-title":"The immunoregulatory role of bone marrow. I. Suppression of the induction of antibody responses to T-dependent and T-independent antigens by cells in the bone marrow","volume":"43","author":"Duwe","year":"1979","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0120","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1073\/pnas.75.10.5142","article-title":"Systemic bacillus Calmette-Gu\u00e9rin (BCG) activates natural suppressor cells","volume":"75","author":"Bennett","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.05.015_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0130","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0135","article-title":"Phenotype, development, and biological function of myeloid-derived suppressor cells","volume":"5","author":"Zhao","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0140","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4049\/jimmunol.1002928","article-title":"Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection","volume":"187","author":"Cuervo","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0145","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.4049\/jimmunol.0903348","article-title":"Mycobacterium bovis bacillus Calmette-Gu\u00e9rin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production","volume":"184","author":"Martino","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0150","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1128\/IAI.69.11.6725-6730.2001","article-title":"Salmonella DNA adenine methylase mutants confer cross-protective immunity","volume":"69","author":"Heithoff","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0155","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1172\/JCI73518","article-title":"Vaccine-induced myeloid cell population dampens protective immunity to SIV","volume":"124","author":"Sui","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.05.015_b0160","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.12768","article-title":"Development and assessment of a new cage-like particle adjuvant","author":"Bertona","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0165","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1128\/IAI.00759-08","article-title":"Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity","volume":"76","author":"Heithoff","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.vaccine.2015.01.044","article-title":"Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease","volume":"33","author":"Bontempi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.015_b0175","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/imt-2017-0009","article-title":"Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi","volume":"9","author":"Bontempi","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.vaccine.2019.05.015_b0180","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4049\/jimmunol.1303432","article-title":"\u03b3\u03b4T cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance","volume":"193","author":"Kong","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.24700","article-title":"Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species","volume":"55","author":"Tacke","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0190","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/JVI.01759-12","article-title":"Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals","volume":"87","author":"Qin","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0195","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/infdis\/jit469","article-title":"HIV type 1 gp120\u2013induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity","volume":"209","author":"Garg","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.015_b0200","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/glycob\/cwv057","article-title":"The trans-sialidase, the major Trypanosoma cruzi virulence factor: three decades of studies","volume":"25","author":"Freire-de-Lima","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0205","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fmicb.2016.00348","article-title":"Role of Trypanosoma cruzi trans-sialidase on the escape from host immune surveillance","volume":"7","author":"Nardy","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0210","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/IAI.00031-15","article-title":"Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells","volume":"83","author":"Ruiz D\u00edaz","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0215","first-page":"723","article-title":"Cell interactions in the induction of tolerance: the role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0220","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0225","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.015_b0230","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.immunol.24.021605.090547","article-title":"FOXP3: of mice and men","volume":"24","author":"Ziegler","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0245","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.12804","article-title":"Phenotypical characterization of regulatory T cells in humans and rodents","volume":"185","author":"Rodr\u00edguez-Perea","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2019.05.015_b0255","doi-asserted-by":"crossref","first-page":"a007021","DOI":"10.1101\/cshperspect.a007021","article-title":"Treg cells, life history, and diversity","volume":"4","author":"Benoist","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/2326-6066.CIR-16-0193","article-title":"Regulatory T cells: differentiation and function","volume":"4","author":"Plitas","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0265","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.015_b0270","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.4049\/jimmunol.180.4.2496","article-title":"Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells","volume":"180","author":"Hisaeda","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0275","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/infdis\/jir820","article-title":"Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells","volume":"205","author":"Trinath","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.015_b0280","doi-asserted-by":"crossref","first-page":"e12154","DOI":"10.1371\/journal.pone.0012154","article-title":"HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta","volume":"5","author":"Hall","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.015_b0285","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1128\/IAI.01146-10","article-title":"Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection","volume":"79","author":"Beswick","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.015_b0290","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1084\/jem.20101074","article-title":"Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-\u03b2 pathway","volume":"207","author":"Grainger","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.05.015_b0295","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/eji.201343701","article-title":"Japanese encephalitis virus expands regulatory T cells by increasing the expression of PD-L1 on dendritic cells","volume":"44","author":"Gupta","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00217","article-title":"Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination","volume":"6","author":"Boer","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0305","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1128\/JVI.00102-08","article-title":"Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection","volume":"82","author":"Cabrera","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0310","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00436-014-4300-3","article-title":"Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease","volume":"114","author":"Bonney","year":"2015","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0315","doi-asserted-by":"crossref","first-page":"e1005698","DOI":"10.1371\/journal.ppat.1005698","article-title":"A human trypanosome suppresses CD8+ T cell priming by dendritic cells through the induction of immune regulatory CD4+ Foxp3+ T cells","volume":"12","author":"Ersching","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.05.015_b0320","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3389\/fimmu.2018.02555","article-title":"Limited Foxp3+ regulatory T cells response during acute Trypanosoma cruzi infection is required to allow the emergence of robust parasite-specific CD8+ T cell immunity","volume":"9","author":"Araujo Furlan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0325","doi-asserted-by":"crossref","first-page":"e65820","DOI":"10.1371\/journal.pone.0065820","article-title":"Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection","volume":"8","author":"Sanoja","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.015_b0330","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/632436","article-title":"CD4+CD25+FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental chagas disease model","volume":"2013","author":"Flores-Garc\u00eda","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2019.05.015_b0335","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1556\/EuJMI.4.2014.2.6","article-title":"Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi","volume":"4","author":"Nihei","year":"2014","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"10.1016\/j.vaccine.2019.05.015_b0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.humpath.2010.10.002","article-title":"Characterization of the presence of Foxp3+ T cells from patients with different clinical forms of Chagas\u2019 disease","volume":"42","author":"de Ara\u00fajo","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0345","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10875-014-0092-6","article-title":"Increase in the expression of CD4 + CD25+ lymphocytic T Cells in the indeterminate clinical form of human chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi","volume":"34","author":"Braz","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2249.2006.03123.x","article-title":"Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas\u2019 disease morbidity?","volume":"145","author":"Vitelli-Avelar","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0355","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1096\/fj.13-229351","article-title":"Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy","volume":"27","author":"Vasconcelos","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2019.05.015_b0360","doi-asserted-by":"crossref","unstructured":"Almeida MS, Lorena VMB, Medeiros C de A, Junior WO, Cavalcanti M da GAM, Martins SM, et al. Alternative Th17 and CD4+CD25+FoxP3+ cell frequencies increase and correlate with worse cardiac function in Chagas cardiomyopathy. Scandinavian J Immunol n.d.;87:e12650. https:\/\/doi.org\/10.1111\/sji.12650.","DOI":"10.1111\/sji.12650"},{"key":"10.1016\/j.vaccine.2019.05.015_b0365","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00477","article-title":"Targeting regulatory T cells to improve vaccine immunogenicity in early life","volume":"5","author":"Ndure","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0370","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1751-7915.2011.00299.x","article-title":"Tregs in infection and vaccinology: heroes or traitors?","volume":"5","author":"Berod","year":"2012","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0375","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2017.11.026","article-title":"Molecular adjuvants that modulate regulatory T cell function in vaccination: a critical appraisal","volume":"129","author":"Batista-Duharte","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0380","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13337-013-0187-3","article-title":"Regulatory T cells as adjuvant target for enhancing the viral disease vaccine efficacy","volume":"25","author":"Bayry","year":"2014","journal-title":"Virusdisease"},{"key":"10.1016\/j.vaccine.2019.05.015_b0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41385-018-0004-9","article-title":"Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection","author":"Lin","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0390","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s00436-017-5581-0","article-title":"Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4+CD25+Foxp3+ regulatory T cells","volume":"116","author":"Tang","year":"2017","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0395","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.micinf.2017.08.013","article-title":"Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice","volume":"19","author":"Wen","year":"2017","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2019.05.015_b0400","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/imm.12006","article-title":"Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+)\/CD4(+) Foxp3(+) cells","volume":"137","author":"Fedatto","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0405","doi-asserted-by":"crossref","first-page":"e1004752","DOI":"10.1371\/journal.ppat.1004752","article-title":"Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity","volume":"11","author":"Brezar","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.05.015_b0410","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12977-016-0258-9","article-title":"Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection","volume":"13","author":"Knuschke","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0415","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.vaccine.2018.03.020","article-title":"Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis","volume":"36","author":"Pereira Silva Bezerra","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.015_b0420","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0425","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.18632\/oncotarget.14991","article-title":"Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2019.05.015_b0430","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2019.05.015_b0435","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/imm.12616","article-title":"Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway","volume":"148","author":"Ren","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.05.015_b0440","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am J Transp"},{"key":"10.1016\/j.vaccine.2019.05.015_b0445","doi-asserted-by":"crossref","first-page":"e0004285","DOI":"10.1371\/journal.pntd.0004285","article-title":"Trypanosoma cruzi experimental infection impacts on the thymic regulatory T cell compartment","volume":"10","author":"Gonz\u00e1lez","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.05.015_b0450","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.052496399","article-title":"Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex","volume":"99","author":"Mucci","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.05.015_b0455","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.05.015_b0460","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4161\/hv.21117","article-title":"The regulatory T cells in anti-influenza antibody response post influenza vaccination","volume":"8","author":"Wang","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.05.015_b0465","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.coi.2013.03.009","article-title":"Human immune responses and potential for vaccine assessment in humanized mice","volume":"25","author":"Akkina","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2019.05.015_b0470","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.chom.2009.06.006","article-title":"Humanized mice for modeling human infectious disease: challenges, progress, and outlook","volume":"6","author":"Legrand","year":"2009","journal-title":"Cell Host Microbe"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:40Z","timestamp":1759401160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":94,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X19306292"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}